Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease

Marketed drugs for Parkinson’s disease (PD) treat disease motor symptoms but are ineffective in stopping or slowing disease progression. In the quest of novel pharmacological approaches that may target disease progression, drug-repurposing provides a strategy to accelerate the preclinical and clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmas, Maria Francesca, Ena, Anna, Burgaletto, Chiara, Casu, Maria Antonietta, Cantarella, Giuseppina, Carboni, Ezio, Etzi, Michela, De Simone, Alfonso, Fusco, Giuliana, Cardia, Maria Cristina, Lai, Francesco, Picci, Luca, Tweedie, David, Scerba, Michael T., Coroneo, Valentina, Bernardini, Renato, Greig, Nigel H., Pisanu, Augusta, Carta, Anna R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130415/
https://www.ncbi.nlm.nih.gov/pubmed/35072912
http://dx.doi.org/10.1007/s13311-022-01182-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130415/
https://www.ncbi.nlm.nih.gov/pubmed/35072912
http://dx.doi.org/10.1007/s13311-022-01182-2

Ejemplares similares